Variation name (cDNA level) | Variation name (protein level) | Variation status | Variation class |
c.IVS32-5C>G (c.4519-5C>G) | Hemizygous | Mutation |
wt codon | wt aa | mutant codon | mutant aa | mutational event | mutation type |
AAC | Asn | spl-5 | Spl. | C->G | Tv |
Structure | Key Residue (HCD) | Pyrimidin doublet | CpG |
At the mRNA level | On restriction map |
r.[4519_4674del, 4518_4519ins4519-4_4519-1, =] | New restriction site(s): none Lost restriction site(s): none |
Impact on splicing | ||||||||||
Splice site type | Wild type sequence | CV | Mutant type sequence | CV | Variation (%) | |||||
TTATGTTTAAACTTA |
| TTATGTTTAAAGTTA |
| 36.7 % |
On isoforms (a blue cell indicates that the corresponding isoform is affected by the mutation) | ||||||
Dp 427c | Dp 427m | Dp 427p | Dp 260 | Dp 140 | Dp 116 | Dp 71 |
Immunofluorescence | ||
dys 1 | dys 2 | dys 3 |
Mosaic Low |
Western Blot | ||
dys 1 | dys 2 | dys 3 |
Sample ID | Patient status | Gender | Transmission | Age of onset | Age of death | Geographic origin |
---282-5-21 | Proband | Male | Unknown | FRANCE |
Phenotypic group |
BMD |
Reference ID | PubMed ID | Reference |
124 | 16077730 | Tuffery-Giraud S, Saquet C, Thorel D, Disset A, Rivier F, Malcolm S, Claustres M. Mutation spectrum leading to an attenuated phenotype in dystrophinopathies. Eur J Hum Genet. 2005, 13(12):1254-60. |